Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079480 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Terminated
- Registry status
- Phase 1
- Development phase
- 130
- Enrollment target
NCT02079480: Clinical Trial Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT02079480 is a Phase 1 study that was terminated before completion, run by Bristol-Myers Squibb. The registered enrollment target is 130 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (117% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02079480, a Phase 1 study, was terminated before completion, sponsored by Bristol-Myers Squibb.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.
Primary Outcome
AE = Adverse event ECG = Electrocardiogram
Interventions
- DRUG BMS-986090
- DRUG Placebo matching with BMS-986090
- DRUG Keyhole limpet hemocyanin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Why NCT02079480 stopped before completion
NCT02079480 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (117% higher).
The record links to 0 conditions, and to 3 interventions - of which BMS-986090 is the first listed.
NCT02079480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02079480 about?
NCT02079480 is a clinical study titled "Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects". The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.
What is the current status of trial NCT02079480?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2014-05. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02079480?
The interventions under investigation include: BMS-986090 (DRUG), Placebo matching with BMS-986090 (DRUG), Keyhole limpet hemocyanin (DRUG).
Who is sponsoring clinical trial NCT02079480?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02079480's enrollment target sits among peer trials
130 439th of 2000 higher than 1,550 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia